Finance

Beta
Lists
TTRX:NASDAQ
Turn Therapeutics Inc
$7.12
+3.94%
(+0.27) 1D
Jul 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TTRX...
Open
$6.94
High
$7.32
Low
$6.83
Mkt. cap
212.09M
Avg. vol.
58.85K
Volume
20.64K
52-wk high
$26.50
52-wk low
$2.57
EPS
-$0.13
Shares outstanding
29.79M
No. of employees
2
Open
$6.94
High
$7.32
Low
$6.83
Mkt. cap
212.09M
Avg. vol.
58.85K
Volume
20.64K
52-wk high
$26.50
52-wk low
$2.57
EPS
-$0.13
Shares outstanding
29.79M
No. of employees
2
News stories
From sources across the web
About Turn Therapeutics Inc
CEO-
Employees2
Founded2015
HeadquartersWestlake Village, California, United States
SectorPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
Karen Sterling
Westpark Capital
Buy
Initiated
$6.15
-13.6%
01/12/2026
Unknown Analyst
WBB Securities
Buy
Initiated
$6.15
-13.6%
01/12/2026
Jason Kolbert
D. Boral Capital
Buy
Initiated
$8.00
+12.4%
12/29/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
496.95K
477.65K
Cost of revenue
-
-
496.95K
477.65K
Research and development expenses
62.68K
158.70K
34.93K
109.43K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.30M
1.75M
2.16M
1.14M
Operating expense
1.37M
1.91M
2.19M
1.25M
Total operating expenses
1.37M
1.91M
2.69M
1.72M
Operating income
-1.37M
-1.91M
-2.69M
-1.72M
Other non operating income
120.98K
4.26K
2.96M
703.14K
EBT including unusual items
-1.24M
-1.90M
279.07K
-970.97K
EBT excluding unusual items
-1.24M
-1.90M
279.07K
-970.97K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.24M
-1.90M
279.07K
-970.97K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-0.04
Interest and investment income
5.13K
5.11K
14.18K
49.68K
Interest expense
-
-
-
-
Net interest expenses
5.13K
5.11K
14.18K
49.68K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.35M
-1.90M
-2.68M
-1.71M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more